FDA Inspection
Neuland Laboratories Limited (Unit I)Neuland Laboratories Limited (Unit I) – FDA Inspection, Apr 7, 2017
Record Details
This FDA Inspection record concerns Neuland Laboratories Limited (Unit I), with an inspection on April 7, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 5cbf351d-bb9c-4c1e-8580-92ab05fb1f90
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1010033
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Neuland Laboratories Limited (Unit I)
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 22, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 21, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 25, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 25, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Neuland Laboratories Limited (Unit I)
- FDA Inspection 1235885 - 2024-03-22
- FDA Inspection 1096367 - 2019-06-21
- FDA Inspection 891418 - 2014-04-25
- FDA Inspection 700774 - 2010-11-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.